Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed. Whether that happens to Seagen is a big question that will impact the Seattle-area biotech community.… Read More
William Canestaro has nurtured a lot of startups. As managing director of Washington Research Foundation and WRF Capital, the foundation’s investment arm, Canestaro helps oversee a portfolio of 40 companies.… Read More
Sujal Patel has been here before. He weathered the 2009 recession as CEO of Isilon Systems, coming out the other end to sell his company the next year for $2.25… Read More
— Maggie Brady, previously a human resources group leader at fintech company Fiserv, is now head of people at trucking marketplace Convoy. Brady previously also led human resources teams at… Read More
Biopharma giant Merck is considering an acquisition of Seagen, the Seattle area’s biggest biotech company, according to a report in the Wall Street Journal Friday. The Journal reported that “talks… Read More
When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
William Canestaro is keenly aware of the risk startup founders take when they go all in to start a company. But as a father of four, he’s more interested in… Read More